REG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5(b) - AbbVie Inc
RNS Number : 6602KBank of America Merrill Lynch23 April 2020FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT
RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY
STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1.
KEY INFORMATION
Name of exempt principal trader
BofA Securities, Inc.
Company dealt in
AbbVie Inc
Class of relevant security to which the
dealings being disclosed relate(Note 1)Common - US00287Y1091
Date of dealing
22/04/2020
2.
INTERESTS AND SHORT POSITIONS
(a)
Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 2)
Class of relevant security: Common
US00287Y1091
Long
Short
Number
%
Number
%
(1)
Relevant securities
217,348
0.015%
2,798,364
0.19 %
(2)
Derivatives (other than options):
2,193,250
0.149%
137,731
0.009%
(3)
Options and agreements to purchase/sell:
7,400
0.001%
7,500
0.001%
Total
2,417,998
0.164%
2,943,595
0.199%
(b)
Interests and short positions in relevant securities of the company, other than the
class dealt in (Note 2)
Class of relevant security:
Long
Short
Number
%
Number
%
(1)
Relevant securities
0
0%
0
0%
(2)
Derivatives (other than options):
0
0%
0
0%
(3)
Options and agreements to purchase/sell:
0
0%
0
0%
Total
0
0%
0
0%
3.
DEALINGS (Note 3)
(a)
Purchases and sales
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Purchase
4,317
81.097 USD
Purchase
8,660
81.43 USD
Purchase
4,009
81.47 USD
Purchase
5,196
81.58 USD
Purchase
5,153
81.659 USD
Purchase
2,600
82.07 USD
Purchase
173
82.18 USD
Purchase
8,673
82.229 USD
Purchase
112
80.36 USD
Purchase
1
80.9 USD
Purchase
1
80.96 USD
Purchase
1
81.06 USD
Purchase
2
81.1 USD
Purchase
1
81.11 USD
Purchase
1
81.14 USD
Purchase
1
81.15 USD
Purchase
1
81.16 USD
Purchase
10
81.17 USD
Purchase
1
81.18 USD
Purchase
2
81.21 USD
Purchase
2
81.22 USD
Purchase
1
81.23 USD
Purchase
1
81.24 USD
Purchase
2
81.25 USD
Purchase
1
81.26 USD
Purchase
3
81.27 USD
Purchase
2
81.31 USD
Purchase
3
81.32 USD
Purchase
1
81.33 USD
Purchase
1
81.34 USD
Purchase
1
81.35 USD
Purchase
101
81.37 USD
Purchase
101
81.38 USD
Purchase
88
81.39 USD
Purchase
23
81.4 USD
Purchase
2
81.42 USD
Purchase
20
81.43 USD
Purchase
1
81.44 USD
Purchase
100
81.45 USD
Purchase
84
81.46 USD
Purchase
300
81.47 USD
Purchase
300
81.49 USD
Purchase
21
81.5 USD
Purchase
579
81.51 USD
Purchase
1
81.515 USD
Purchase
327
81.52 USD
Purchase
112
81.53 USD
Purchase
57
81.54 USD
Purchase
17
81.55 USD
Purchase
22
81.56 USD
Purchase
117
81.57 USD
Purchase
75
81.58 USD
Purchase
184
81.59 USD
Purchase
125
81.6 USD
Purchase
26
81.61 USD
Purchase
5
81.62 USD
Purchase
329
81.63 USD
Purchase
145
81.64 USD
Purchase
268
81.65 USD
Purchase
84
81.66 USD
Purchase
72
81.67 USD
Purchase
30
81.68 USD
Purchase
85
81.69 USD
Purchase
8
81.7 USD
Purchase
181
81.71 USD
Purchase
25
81.72 USD
Purchase
302
81.73 USD
Purchase
151
81.74 USD
Purchase
162
81.75 USD
Purchase
23
81.76 USD
Purchase
59
81.77 USD
Purchase
9
81.78 USD
Purchase
26
81.79 USD
Purchase
50
81.8 USD
Purchase
9
81.81 USD
Purchase
4
81.83 USD
Purchase
7
81.85 USD
Purchase
2
81.88 USD
Purchase
8
81.92 USD
Purchase
6
81.94 USD
Purchase
14
81.95 USD
Purchase
6
81.96 USD
Purchase
4
81.97 USD
Purchase
3
82.02 USD
Purchase
6
82.07 USD
Purchase
7
82.09 USD
Purchase
4
82.12 USD
Purchase
6
82.14 USD
Purchase
4
82.18 USD
Purchase
13
82.19 USD
Purchase
10
82.22 USD
Purchase
4
82.23 USD
Purchase
9
82.24 USD
Purchase
5
82.25 USD
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Sale
112
80.36 USD
Sale
174
80.83 USD
Sale
1
80.89 USD
Sale
1
80.94 USD
Sale
1
80.97 USD
Sale
1
80.99 USD
Sale
1
81 USD
Sale
2
81.02 USD
Sale
201
81.04 USD
Sale
1
81.05 USD
Sale
24
81.06 USD
Sale
121
81.07 USD
Sale
690
81.08 USD
Sale
1
81.085 USD
Sale
1,154
81.09 USD
Sale
1,177
81.1 USD
Sale
516
81.11 USD
Sale
90
81.12 USD
Sale
246
81.13 USD
Sale
279
81.14 USD
Sale
1
81.145 USD
Sale
5
81.15 USD
Sale
209
81.16 USD
Sale
11
81.17 USD
Sale
73
81.18 USD
Sale
213
81.19 USD
Sale
88
81.2 USD
Sale
1
81.21 USD
Sale
2
81.22 USD
Sale
89
81.23 USD
Sale
108
81.24 USD
Sale
291
81.25 USD
Sale
187
81.26 USD
Sale
176
81.27 USD
Sale
473
81.28 USD
Sale
461
81.29 USD
Sale
370
81.3 USD
Sale
281
81.31 USD
Sale
265
81.32 USD
Sale
135
81.33 USD
Sale
346
81.34 USD
Sale
287
81.35 USD
Sale
123
81.36 USD
Sale
198
81.37 USD
Sale
304
81.38 USD
Sale
130
81.381 USD
Sale
398
81.39 USD
Sale
1,003
81.4 USD
Sale
737
81.41 USD
Sale
210
81.42 USD
Sale
272
81.43 USD
Sale
701
81.44 USD
Sale
313
81.45 USD
Sale
4
81.455 USD
Sale
1,061
81.46 USD
Sale
5,785
81.47 USD
Sale
100
81.475 USD
Sale
228
81.48 USD
Sale
87
81.485 USD
Sale
122
81.49 USD
Sale
492
81.5 USD
Sale
20
81.51 USD
Sale
226
81.52 USD
Sale
721
81.53 USD
Sale
228
81.54 USD
Sale
128
81.55 USD
Sale
223
81.56 USD
Sale
1
81.565 USD
Sale
3
81.57 USD
Sale
3
81.58 USD
Sale
186
81.59 USD
Sale
483
81.6 USD
Sale
119
81.61 USD
Sale
628
81.62 USD
Sale
1,536
81.63 USD
Sale
2,955
81.64 USD
Sale
127
81.645 USD
Sale
2,394
81.65 USD
Sale
9
81.652 USD
Sale
2,804
81.66 USD
Sale
1,455
81.67 USD
Sale
1,809
81.68 USD
Sale
21,650
81.683 USD
Sale
82
81.685 USD
Sale
896
81.69 USD
Sale
880
81.7 USD
Sale
92
81.71 USD
Sale
2
81.715 USD
Sale
74
81.72 USD
Sale
4
81.725 USD
Sale
656
81.73 USD
Sale
942
81.74 USD
Sale
3
81.745 USD
Sale
404
81.75 USD
Sale
724
81.76 USD
Sale
1,058
81.77 USD
Sale
86
81.775 USD
Sale
215
81.78 USD
Sale
30
81.79 USD
Sale
19
81.8 USD
Sale
271
81.81 USD
Sale
34
81.82 USD
Sale
27
81.85 USD
Sale
32
81.89 USD
Sale
16
81.9 USD
Sale
154
81.91 USD
Sale
2
81.92 USD
Sale
179
81.93 USD
Sale
486
81.94 USD
Sale
188
81.95 USD
Sale
273
81.96 USD
Sale
100
81.965 USD
Sale
200
81.97 USD
Sale
127
81.98 USD
Sale
143
81.99 USD
Sale
157
82 USD
Sale
100
82.01 USD
Sale
462
82.05 USD
Sale
273
82.07 USD
Sale
658
82.08 USD
Sale
145
82.09 USD
Sale
1
82.1 USD
Sale
223
82.11 USD
Sale
325
82.12 USD
Sale
172
82.13 USD
Sale
240
82.14 USD
Sale
273
82.15 USD
Sale
833
82.16 USD
Sale
360
82.17 USD
Sale
200
82.18 USD
Sale
229
82.19 USD
Sale
1,301
82.2 USD
Sale
473
82.21 USD
Sale
286
82.22 USD
Sale
1,310
82.23 USD
Sale
359
82.235 USD
Sale
2,045
82.24 USD
Sale
2,395
82.245 USD
Sale
228
82.25 USD
Sale
300
82.26 USD
Sale
600
82.27 USD
Sale
27
82.32 USD
Sale
43,300
81.31 USD
Sale
12,904
81.4 USD
Sale
2,252
81.47 USD
Sale
15,207
82.2 USD
(b)
Derivatives transactions (other than options transactions)
Product name,
e.g. CFDNature of transaction
(Note 5)Number of relevant securities
(Note 6)Price per unit
(Note 4)Swaps
Reducing a Short Position
9
81.651 USD
Swaps
Increasing a Long Position
8,660
81.43 USD
Swaps
Increasing a Long Position
12,990
81.852 USD
Swaps
Reducing a Long Position
41
81.306 USD
(c)
Options transactions in respect of existing relevant securities
(i)
Writing, selling, purchasing or varying
Product name, e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise price
Type, e.g. American, European etc
Expiry date
Option money paid/ received per unit (Note 4)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(ii)
Exercising
Product name,
e.g. call optionNumber of securities
Exercise price per
unit (Note 4)N/A
N/A
N/A
(d)
Other dealings (including transactions in respect of new securities) (Note 3)
Nature or transaction
(Note 7)Details
Price per unit
(if applicable) (Note 4)
Borrow
Borrow of 91,100 shares
N/A
Borrow
Borrow of 414,900 shares
N/A
Borrow
Borrow of 239,500 shares
N/A
Borrow
Borrow of 123,100 shares
N/A
Return of Borrow
2,600 shares returned
N/A
4.
OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting rights
or future acquisition or disposal of any relevant securities to which any derivative
referred to on this form is referenced. If none, this should be stated.None
Is a Supplemental Form 38.5(b) attached? (Note 8)
Yes
Date of disclosure
23/04/2020
Contact name
Tolu Tade
Telephone number
+44207 996 3410
Name of offeree/offeror with which connected
AbbVie Inc
Nature of connection (Note 9)
Advisor to - AbbVie Inc
SUPPLEMENTAL FORM 38.5(b)
DISCLOSURE UNDER RULE 38.5 (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
Product name,
e.g. call optionWritten or
purchasedNumber of securities to which the option or derivative relates
Exercise price
(Note 2)Type, e.g.
American,
European etcExpiry date
Call Option
Written
7,500
105 USD
American
15/01/2021
Call Option
Purchased
7,400
85 USD
American
15/01/2021
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDISEFIFEASAIVFII
Recent news on Abbvie
See all newsRCS - Ripple Therapeutics - Ripple Therapeutics Announces Collaboration
AnnouncementREG - Stock Exch Notice - Admission to ISM - 20/06/2024
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
Announcement